FDA Drug GMP Warning Letter Usage Remains Low In FY 2004
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency issues 30 drug good manufacturing practices warning letters in fiscal year 2004, compared to 29 a year earlier. Sixteen of the 30 warning letters addressed stability program deficiencies, while equipment cleaning and QC unit problems appeared in half.